Tranexamic Acid Injection 500mg/5ml, GMP Medicine

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: For external use
Still deciding? Get samples of US$ 0/vials
Request Sample
Manufacturer/Factory, Trading Company

360° Virtual Tour

Diamond Member Since 2015

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Years of Export Experience
The export experience of the supplier is more than 10 years
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Importers and Exporters
The supplier has import and export rights
Management Certification
The supplier has quality management system certification, including:
ISO9001:2015 certificate
ISO45001:2018 certificate
ISO14001
to see all verified strength labels (20)
  • Tranexamic Acid Injection 500mg/5ml, GMP Medicine
  • Tranexamic Acid Injection 500mg/5ml, GMP Medicine
  • Tranexamic Acid Injection 500mg/5ml, GMP Medicine
  • Tranexamic Acid Injection 500mg/5ml, GMP Medicine
  • Tranexamic Acid Injection 500mg/5ml, GMP Medicine
  • Tranexamic Acid Injection 500mg/5ml, GMP Medicine
Find Similar Products

Basic Info.

Model NO.
AMC14072
Suitable for
Elderly, Adult
State
Liquid
Transport Package
10vials/Box
Specification
500mg/5ml
Trademark
Medipharm, OEM
Origin
China
HS Code
3004909099
Production Capacity
2000000 Vials Per Month

Product Description

Tranexamic Acid Injection 500mg/5ml, GMP Medicine

 Indications:
This product is mainly used for the treatment of acute or chronic, localized or systemic primary fibrinolysis caused by various bleeding, this product can also be used:
1. Trauma or surgical bleeding of plasminogen activator in prostate, urethra, lung, brain, uterus, adrenal gland, thyroid gland and other organs;
2. Used as an antagonist of tissue plasminogen activator (T-PA) streptokinase and urokinase;
3. Induced abortion, early placental abruption, stillbirth and amniotic fluid embolism caused by fibrinolytic bleeding, and pathologic intrauterine local increased fibrinolytic menorrhagia;
4. Used to prevent or reduce bleeding after tooth extraction or oral surgery for hemophiliacs lacking factor
5. Mild bleeding caused by central nervous diseases, such as subarachnoid hemorrhage and intracranial aneurysm hemorrhage, hemostasis using this product is superior to other anti-fibrinolytic drugs, but the risk of complicated cerebral edema or cerebral infarction must be paid attention to; For severe patients with surgical indications, this product can only be used as an adjuvant;
6. For the treatment of hereditary angoneeurotic edema, can reduce the frequency and severity of its attack;
7. Hemophilia patients with active bleeding can be combined with this drug.
Usage and Dosage:

Pulse injection or infusion, 0.25 ~ 0.5g, 0.75 ~ 2g a day. In order to prevent bleeding before and after surgery, the dose mentioned above can be referred to. In order to treat bleeding caused by primary fibrinolysis, the dose can be increased as appropriate.
Interactions:
1. Incompatibility with penicillin, urokinase and other suppositories or blood infusion;
2. The combination of oral contraceptives, estrogen or prothrombin complex with this product may increase the risk of thrombosis.
Storage:
Shading, airtight storage (10 ~ 30ºC).

 

Tranexamic Acid Injection 500mg/5ml, GMP MedicineTranexamic Acid Injection 500mg/5ml, GMP Medicine
Tranexamic Acid Injection 500mg/5ml, GMP MedicineTranexamic Acid Injection 500mg/5ml, GMP MedicineTranexamic Acid Injection 500mg/5ml, GMP MedicineTranexamic Acid Injection 500mg/5ml, GMP Medicine

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier